Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
What do we really know about antibiotic pharmacodynamics?
B. W. Gunderson
, G. H. Ross
, K. H. Ibrahim
, J. C. Rotschafer
Experimental and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
91
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'What do we really know about antibiotic pharmacodynamics?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacodynamics
100%
Antibiotics
100%
Antibiotic Concentration
18%
Vancomycin
9%
Bacterial Pathogens
9%
Minimum Inhibitory Concentration
9%
Lactams
9%
Antibiotic Resistance
9%
System Modeling
9%
Clinical Validation
9%
New Antibiotics
9%
Adverse Drug Reaction
9%
Pharmacokinetic-pharmacodynamic Modeling
9%
Aminoglycosides
9%
Concentration-dependent
9%
Drug Concentration
9%
Severe Infection
9%
Human Data
9%
Area under the Concentration-time Curve
9%
Cmax
9%
Fluoroquinolones
9%
Time Duration
9%
Chemical Classes
9%
Formulary
9%
Daily Clinical Practice
9%
Pharmacological Activities
9%
Concentration Effect
9%
Formulary Committees
9%
AUC0-24
9%
Antibiotic Strategies
9%
Macrolides
9%
Bacterial Death
9%
Pharmacologic Effects
9%
Concentration-independent
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacodynamics
100%
Antibiotics
57%
Pharmacodynamic Parameter
28%
Infectious Agent
14%
Minimum Inhibitory Concentration
14%
Drug Concentration
14%
Lactam
14%
Adverse Drug Reaction
14%
Pharmacodynamic Modeling
14%
Macrolide
14%
Infection
14%
Prematurity
14%
Quinolone Derivative
14%
Vancomycin
14%
Aminoglycoside
14%
Drug Action
14%
Antibiotic Resistance
14%